Mike Zablocki
General Manager
Mike is General Manager of the Malaghan Institute, responsible for the corporate, commercial and support functions of the organisation. He is also a Director of Wellington Zhaotai Therapies Limited, a joint venture established by the Malaghan Institute to develop innovative cell therapies for the global market.
Mike completed a Bachelor of Arts at the University of Bristol, before moving to New Zealand in 2002 when he joined the Malaghan as a database administrator. In 2011 he completed his Postgraduate Diploma in Business Administration at Victoria University of Wellington. He was appointed as General Manager in 2016.
Cancer: Same name, different diseases
23 September 2026
New clinical research core to help take research from benchtop to bedside
8 September 2026
Research offers new approach to vaccine design for broader immunity
27 August 2026
Reading the immune system, one puzzle piece at a time
26 August 2026
Clinical study to uncover the origins of a severe type of Crohn’s disease
26 August 2026
Malaghan visiting researcher: Dr Lauren Holz
28 July 2026
Cancer: Same name, different diseases
23 September 2026
New clinical research core to help take research from benchtop to bedside
8 September 2026
Research offers new approach to vaccine design for broader immunity
27 August 2026
Reading the immune system, one puzzle piece at a time
26 August 2026
Clinical study to uncover the origins of a severe type of Crohn’s disease
26 August 2026
Malaghan visiting researcher: Dr Lauren Holz
28 July 2026